Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Condition:   Prostate CancerIntervention:   Drug: lapatinib ditosylateSponsors:   UNC Lineberger Comprehensive Cancer Center;   National Cancer Institute (NCI)Completed - verified December 2014

Source: ClinicalTrials.gov - October 28, 2005 Category: Research Source Type: clinical trials